CLACKSON TIMOTHY P 4
4 · Theseus Pharmaceuticals, Inc. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
CLACKSON TIMOTHY P
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Units
2023-03-01+45,625→ 45,625 total→ Common Stock (45,625 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
- [F2]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the RSUs vesting on March 1, 2024 and 1/16th of the RSUs vesting quarterly thereafter, subject to the Reporting Person's continuous service with the issuer. The RSUs have no expiration date.